DELAWARE VALLEY NODE (no longer active)

George E. Woody, MD [email]
Principal Investigator
Department of Psychiatry
University of Pennsylvania
Treatment Research Institute
600 Public Ledger Bldg.
150 S. Independence Mall - West
Philadelphia, PA 19106-3475
Find Node Publications
Node Facebook page

Node web site
NIDA web site

The Delaware Valley Node joined the Clinical Trials Network in September 1999 and includes Delaware, Eastern Pennsylvania, and New Jersey. The DV Node member organizations provide services to patients with every type of substance use disorder including special populations such as: 1) persons living with HIV, 2) adolescents, 3) veterans, 4) women with children, and 5) patients living in rural areas.

This node is no longer active in the CTN.


CTN-0002 Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification
CTN-0004 MET to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
CTN-0006 Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
CTN-0007 Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
CTN-0008 Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation
CTN-0010 Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescent/Young Adults
CTN-0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
CTN-0018 Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment
CTN-0019 Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment
CTN-0027 Starting Treatment with Agonist Replacement Therapies (START)
CTN-0027-A-1 START Pharmacogenetics: Exploratory Genetic Studies in Starting Treatment with Agonist Replacement Therapies
CTN-0027-A-2 Retention of Suboxone Patients in START: Perspectives of Providers and Patients
CTN-0028 Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents (with Substance Use Disorder)
CTN-0037 Stimulant Reduction Intervention Using Dosed Exercise (STRIDE)
CTN-0037-A-1 Site Influences on Treatment Effects - Exercise as a Treatment for Substance Use Disorders
CTN-0049 Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users (Project HOPE)
CTN-0050 Long Term Follow-Up of START Patients
CTN-0052 A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence (BRAC)
CTN-0064 Linkage to Hepatitis C Virus (HCV) Care among HIV/HCV Co-infected Substance Users

University of Pennsylvania School of Medicine Treatment Research Institute
RRTC Site | www
RRTC Site | www
Christiana Care Health System Penn Presbyterian
www | search
www | search
Caron Perelman School of Medicine
www | search
www | search
Firetree, Ltd. Philadelphia Health Management Corporation
www | search
www | search
Jonathan LAX Center Rehab After Work
www | search
www | search
Northeast Treatment Centers Thomas Jefferson University Hospital
www | search www | search
Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 5/2015 --